China Junshi’s potential COVID drug shows promise in small trial
The drug, called VV116, is a derivative of Gilead Sciences's COVID drug Remdesivir and was approved for use in moderate-to-severe…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Estrogen treatment linked with reduced COVID mortality: Study
The research, published in the journal 'Family Practice,' analysed the association between hormone replacement therapy or combined…
AstraZeneca boosts COVID portfolio with RQ Bio deal
The deal gives AstraZeneca the rights to develop and sell six antibodies, none of which has been tested in humans so far
Valneva receives EUA from UAE for its inactivated COVID-19 vaccine
This authorisation follows conditional marketing authorisation from the UK MHRA, which was granted last month, and EUA from the…
FDA declines to authorise common antidepressant as COVID treatment
The generic drug belongs to an old, widely-used class of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs)
Biological E reduces Corbevax price to Rs 250 a dose
The decision comes within weeks of Biological E receiving the Emergency Use Authorisation (EUA) for children between five and 12…
Unable to sell Sputnik Light stock, Stelis Biopharma requests PM Modi for procurement of jabs
The Drugs Controller General of India (DCGI) had granted emergency use permission to Sputnik Light, subject to certain regulatory…
Switzerland authorises Moderna’s COVID vaccine for six-to-11-year olds
The approval is for the vaccine’s two-dose series of 50 micro gram per dose
Pfizer, EU push back COVID vaccine delivery to help booster campaign
The companies amended their supply agreement with the European Commission to push back delivery of doses scheduled for June…
Moderna completes FDA submission for use of COVID shot in adolescents, kids
The company is seeking approval for the use of its vaccines in three distinct age groups - adolescents aged 12 to 17 years,…
Biological E seeks EUA for Corbevax as booster COVID-19 dose for adults
The Drugs Controller General Of India (DCGI) had already approved Corbevax, India's first indigenously developed RBD protein…
Fourth COVID-19 vaccine dose provides strong immunity boost: UK study
Fourth doses of COVID-19 vaccines have been offered as a spring booster for those most vulnerable in the UK, researchers said
Inovio to discontinue COVID vaccine trial, appoints Jacqueline Shea as CEO
The decision on the trial comes after emerging global data showed a lower incidence of severe COVID cases, which would lead to an…
CEPI partners with consortium of Bharat Biotech, University of Sydney and ExcellGene to develop…
CEPI will fund the researchers to conduct activities including immunogen design, pre-clinical studies, manufacturing process…
BioNTech completes phase-II trial of COVID-19 vaccine in China
The vaccine, based on messenger RNA (mRNA) technology, is one of the most widely used worldwide against COVID, but has yet to…
Cipla partners with Genes2Me for commercialisation of ‘RT-Direct’ multiplex COVID-19 RT PCR test kit
RNA extraction free kit to deliver results in 45 minutes
Oral COVID vaccine protects against disease, transmission: Study
The research, published in the journal "Science Translational Medicine," demonstrates the potential of the vaccine to work through…
UK health service rolls out arthritis drug Baricitinib to treat COVID
Arthritis drugs work by reducing inflammation caused by COVID-19 by blocking signals to the immune system that are causing it to…
Africa CDC calls for COVID vaccine orders from S Africa’s Aspen
The Africa Centre for Disease Control and Prevention (CDC) said it was doing everything it could behind the scenes to prevent a…
AstraZeneca COVID booster shot effective against severe disease, finds UK study
The researchers from the UK Health Security Agency, London, estimated vaccine effectiveness by analysing data on all adults aged…